Acteoside and ursolic acid synergistically protects H2O2-induced neurotrosis by regulation of AKT/mTOR signalling: from network pharmacology to experimental validation. (31st December 2022)
- Record Type:
- Journal Article
- Title:
- Acteoside and ursolic acid synergistically protects H2O2-induced neurotrosis by regulation of AKT/mTOR signalling: from network pharmacology to experimental validation. (31st December 2022)
- Main Title:
- Acteoside and ursolic acid synergistically protects H2O2-induced neurotrosis by regulation of AKT/mTOR signalling: from network pharmacology to experimental validation
- Authors:
- Qu, Yan-Jie
Ding, Min-Rui
Gu, Chao
Zhang, Li-Min
Zhen, Rong-Rong
Chen, Jin-Fang
Hu, Bing
An, Hong-Mei - Abstract:
- Abstract: Context: Ursolic acid (UA) and acteoside (ATS) are important active components that have been used to treat Alzheimer's disease (AD) because of their neuroprotective effects, but the exact mechanism is still unclear. Objective: Network pharmacology was used to explore the mechanism of UA + ATS in treating AD, and cell experiments were used to verify the mechanism. Materials and methods: UA + ATS targets and AD-related genes were retrieved from TCMSP, STITCH, SwissTargetPrediction, GeneCards, DisGeNET and GEO. Key targets were obtained by constructing protein interaction network through STRING. The neuroprotective effects of UA + ATS were verified in H2 O2 -treated PC12 cells. The subsequent experiments were divided into Normal, Model (H2 O2 pre-treatment for 4 h), Control (H2 O2 + solvent pre-treatment), UA (5 μM), ATS (40 μM), UA (5 μM) + ATS (40 μM). Then apoptosis, mitochondrial membrane potential, caspase-3 activity, ATG5, Beclin-1 protein expression and Akt, mTOR phosphorylation levels were detected. Results: The key targets of UA + ATS-AD network were mainly enriched in Akt/mTOR pathway. Cell experiments showed that UA (ED50 : 5 μM) + ATS (ED50 : 40 μM) could protect H2 O2 -induced (IC50 : 250 μM) nerve damage by enhancing cells viability, combating apoptosis, restoring MMP, reducing the activation of caspase-3, lessening the phosphorylation of Akt and mTOR, and increasing the expression of ATG5 and Beclin-1. Conclusions: ATS and UA regulates multipleAbstract: Context: Ursolic acid (UA) and acteoside (ATS) are important active components that have been used to treat Alzheimer's disease (AD) because of their neuroprotective effects, but the exact mechanism is still unclear. Objective: Network pharmacology was used to explore the mechanism of UA + ATS in treating AD, and cell experiments were used to verify the mechanism. Materials and methods: UA + ATS targets and AD-related genes were retrieved from TCMSP, STITCH, SwissTargetPrediction, GeneCards, DisGeNET and GEO. Key targets were obtained by constructing protein interaction network through STRING. The neuroprotective effects of UA + ATS were verified in H2 O2 -treated PC12 cells. The subsequent experiments were divided into Normal, Model (H2 O2 pre-treatment for 4 h), Control (H2 O2 + solvent pre-treatment), UA (5 μM), ATS (40 μM), UA (5 μM) + ATS (40 μM). Then apoptosis, mitochondrial membrane potential, caspase-3 activity, ATG5, Beclin-1 protein expression and Akt, mTOR phosphorylation levels were detected. Results: The key targets of UA + ATS-AD network were mainly enriched in Akt/mTOR pathway. Cell experiments showed that UA (ED50 : 5 μM) + ATS (ED50 : 40 μM) could protect H2 O2 -induced (IC50 : 250 μM) nerve damage by enhancing cells viability, combating apoptosis, restoring MMP, reducing the activation of caspase-3, lessening the phosphorylation of Akt and mTOR, and increasing the expression of ATG5 and Beclin-1. Conclusions: ATS and UA regulates multiple targets, bioprocesses and signal pathways against AD pathogenesis. ATS and UA synergistically protects H2 O2 -induced neurotrosis by regulation of AKT/mTOR signalling. … (more)
- Is Part Of:
- Pharmaceutical biology. Volume 60:Number 1(2022)
- Journal:
- Pharmaceutical biology
- Issue:
- Volume 60:Number 1(2022)
- Issue Display:
- Volume 60, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 60
- Issue:
- 1
- Issue Sort Value:
- 2022-0060-0001-0000
- Page Start:
- 1751
- Page End:
- 1761
- Publication Date:
- 2022-12-31
- Subjects:
- Neuroprotection -- apoptosis -- mTOR-dependent autophagy -- Rehmannia glutinosa (Gaetn.) Libosch. ex Fisch. et Mey. -- Cornus officinalis Sieb. et Zucc
Pharmacognosy -- Periodicals
Materia medica, Vegetable -- Periodicals
615.321 - Journal URLs:
- http://www.tandfonline.com/toc/iphb20/current ↗
http://informahealthcare.com/journal/phb ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13880209.2022.2098344 ↗
- Languages:
- English
- ISSNs:
- 1388-0209
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6442.767000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23909.xml